Martin Fenner
Martin Fenner
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
S Krege, J Beyer, R Souchon, P Albers, W Albrecht, F Algaba, M Bamberg, ...
European urology 53 (3), 478-496, 2008
X Inactivation in the Mouse Embryo Deficient for Dnmt1: Distinct Effect of Hypomethylation on Imprinted and Random X Inactivation
T Sado, MH Fenner, SS Tan, P Tam, T Shioda, E Li
Developmental biology 225 (2), 294-303, 2000
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer, J Busch, ...
Annals of oncology 24 (4), 878-888, 2013
ORCID: a system to uniquely identify researchers
LL Haak, M Fenner, L Paglione, E Pentz, H Ratner
Learned Publishing 25 (4), 259-264, 2012
Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer
J Atzpodien, H Kirchner, EL Hänninen, M Deckert, M Fenner, H Poliwoda
European Journal of Cancer 29, S6-S8, 1993
PPARγ ligands and ATRA inhibit the invasion of human breast cancer cells in vitro
H Liu, C Zang, MH Fenner, K Possinger, E Elstner
Breast cancer research and treatment 79 (1), 63-74, 2003
Altmetrics in evolution: Defining and redefining the ontology of article-level metrics
J Lin, M Fenner
Information standards quarterly 25 (2), 20, 2013
Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator
T Shioda, RJ Lechleider, SL Dunwoodie, H Li, T Yahata, ...
Proceedings of the National Academy of Sciences 95 (17), 9785-9790, 1998
Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer
MH Fenner, E Elstner
Expert opinion on investigational drugs 14 (6), 557-568, 2005
Novel therapeutic approach: ligands for PPARγ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells
E Elstner, EA Williamson, C Zang, J Fritz, D Heber, M Fenner, K Possinger, ...
Breast cancer research and treatment 74 (2), 155-165, 2002
Altmetrics and other novel measures for scientific impact
M Fenner
Opening science, 179-189, 2014
Sharing and reuse of individual participant data from clinical trials: principles and recommendations
C Ohmann, R Banzi, S Canham, S Battaglia, M Matei, C Ariyo, L Becnel, ...
BMJ open 7 (12), e018647, 2017
msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation
T Shioda, MH Fenner, KJ Isselbacher
Proceedings of the National Academy of Sciences 93 (22), 12298-12303, 1996
What can article-level metrics do for you?
M Fenner
PLoS Biol 11 (10), e1001687, 2013
Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18
H Liu, C Zang, MH Fenner, D Liu, K Possinger, HP Koeffler, E Elstner
Blood 107 (9), 3683-3692, 2006
Ligands for PPARγ and RAR cause induction of growth inhibition and apoptosis in human glioblastomas
C Zang, M Wächter, H Liu, MG Posch, MH Fenner, C Stadelmann, ...
Journal of neuro-oncology 65 (2), 107-118, 2003
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular …
K Oechsle, F Honecker, T Cheng, F Mayer, P Czaykowski, E Winquist, ...
Annals of oncology 22 (12), 2654-2660, 2011
Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in …
S Krege, H Rexer, F vom Dorp, P de Geeter, T Klotz, M Retz, ...
BJU international 113 (3), 429-436, 2014
MSG1 and its related protein MRG1 share a transcription activating domain
T Shioda, MH Fenner, KJ Isselbacher
Gene 204 (1-2), 235-241, 1997
European studies of interleukin-2 in metastatic renal cell carcinoma
J Atzpodien, H Kirchner, EL Hänninen, A Körfer, M Fenner
Seminars in oncology 20 (6), 22-26, 1993
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20